J Med Microbiol International Journal of Systematic and Evolutionary Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bottone, E. J.
Right arrow Articles by Peluso, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bottone, E. J.
Right arrow Articles by Peluso, R. W.
Agricola
Right arrow Articles by Bottone, E. J.
Right arrow Articles by Peluso, R. W.
J Med Microbiol 52 (2003), 69-74; DOI: 10.1099/jmm.0.04935-0
© 2003 Society for General Microbiology
ISSN 0022-2615


ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Production by Bacillus pumilus (MSH) of an antifungal compound that is active against Mucoraceae and Aspergillus species: preliminary report

Edward J. Bottone and Richard W. Peluso

Department of Medicine, Division of Infectious Diseases, The Mount Sinai Hospital and Department of Microbiology, One Gustave L. Levy Place, Mount Sinai School of Medicine, New York, NY 10029, USA

Correspondence Edward J. Bottone edward.bottone{at}mssm.edu

Received 9 April 2002 Accepted 18 August 2002

A compound produced by Bacillus pumilus (MSH) that inhibits Mucoraceae and Aspergillus species is described. Fungicidal activity was demonstrated by lawn-spotting and by diffusion through 0.45 µm Millipore membranes placed on 5 % sheep-blood agar, nutrient agar, trypticase soy agar and Mueller–Hinton agar, followed by spore inoculation of the bacterium-free underlying agar surface. With either technique, zones of fungal inhibition correlated with the zone of haemolysis produced by B. pumilus (MSH). The active compound inhibited Mucor and Aspergillus spore germination and aborted elongating hyphae, presumably by inducing a cell-wall lesion. Antifungal activity was stable in agar for a minimum of 8 days, resistant to Pronase degradation, and partially inactivated by chloroform exposure and at pH 5.6. Its molecular mass was determined by diffusion through dialysis membrane to be 500–3000 Da. Attempts at further isolation of the compound have proven unsuccessful to date.




This article has been cited by other articles:


Home page
J Med MicrobiolHome page
V Yadav, R Mandhan, R. Dabur, A K Chhillar, J Gupta, and G L Sharma
A fraction from Escherichia coli with anti-Aspergillus properties
J. Med. Microbiol., April 1, 2005; 54(4): 375 - 379.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2003 Society for General Microbiology.